Advertisement
News
Subscribe to MDT Magazine News

Heavyweights from the Primes, DoD and NASA to Address Challenges for Aerospace and Defense Manufacturers Under Today's Tight Budgets

February 4, 2011 7:36 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 3, 2011 — The senior-most executives from aerospace and defense manufacturing are gathering this spring at AeroDef 2011 Manufacturing Exposition and Conference to address the challenges facing the major OEMs and their supply chains, under pressure to...

58% of Physicians Support FDA Move to Pull Breast Cancer Indication from Avastin

February 4, 2011 7:35 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., Feb. 4, 2011 /- Sermo ( http://www.sermo.com ), the world's largest online community for physicians, announced the publication of a free Sermo Report about how physicians are reacting to the FDA decision to rescind the indication for Avastin (bevacizumab) in the...

TOPICS:

Photocure Announces Positive Allumeraâ„¢ Trial Results for Delivering Significant Skin Appearance Improvements

February 4, 2011 7:35 am | by Bio-Medicine.Org | Comments

OSLO, Norway, Feb. 4, 2011 /- Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused in dermatology and cancer, today announced positive results from its consumer trial with Allumera™, a breakthrough cosmetic treatment formulated to improve the skin's appearance....

TOPICS:
Advertisement

Earnings Preview: Humana reports 4Q earnings

February 4, 2011 6:45 am | by The Associated Press | Comments

Health insurer Humana Inc. reports fourth-quarter financial results on Monday before the market opens.WHAT TO WATCH FOR: Humana said late last year that its forecast for 2011 earnings would slip by about a dollar per share from the prior year due mainly to less favorable trends for its crucial...

R.I. council awards $1.4M to eight projects

February 4, 2011 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

The Rhode Island Science and Technology Advisory Council (STAC) has singled out eight research projects and 23 scientists from 13 institutions for a total of $1.4 million in grants.

Avecia Biotechnology acquired by Japanese firm

February 4, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Avecia Biotechnology Inc., a DNA- and RNA-based therapeutics firm in Milford, has been acquired by Japanese materials manufacturer Nitto Denko Corp.

Federal Register: Industry Exchange Workshop on Food and Drug Administration Drug and Device Requirements; Public Workshop

February 4, 2011 5:30 am | by U.S. Food & Drug Administration | Comments

This 2-day public workshop is intended to provide information about FDA drug and device regulation to the regulated industry.

TOPICS:

Stock futures rise after employment report

February 4, 2011 4:45 am | by DAVID K. RANDALL - AP Business Writer - Associated Press | Comments

U.S. stocks were poised to open slightly higher Friday after the unemployment rate fell more than economists had predicted even as the number of jobs created came in below expectations.The government said that unemployment in January dropped to 9.0 percent from 9.4 percent in December....

Advertisement

MEDfx to Harmonize the Direct Project With CONNECT

February 4, 2011 4:35 am | by Bio-Medicine.Org | Comments

WARWICK, R.I., Feb. 4, 2011 /- MEDfx Corporation today announced a Direct Project pilot that demonstrates health information exchange among providers using a combination of the standards and protocols supported by the Direct Project and the FHA CONNECT Gateway. MEDfx is participating in,...

TOPICS:

FDA Approves Makenaâ„¢, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm ...

February 4, 2011 4:33 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Feb. 4, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. that the U.S. Food and Drug Administration (FDA) granted approval for Makena™ (hydroxyprogesterone...

TOPICS:

FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women

February 4, 2011 4:33 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one...

TOPICS:

FDA Approves Hologic's Makenaâ„¢ (Formerly Referred to as Gestivaâ„¢) Pharmaceutical

February 4, 2011 4:33 am | by Bio-Medicine.Org | Comments

BEDFORD, Mass., Feb. 4, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the...

TOPICS:

Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders

February 4, 2011 4:33 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Feb. 4, 2011 /- Novo Nordisk announced today the availability of Coags Uncomplicated – the first mobile application (app) to assist in the diagnosis of bleeding disorders – created in partnership with Craig Kessler, MD, Professor of Medicine and Pathology and...

TOPICS:

WebMD to Present at the UBS 21st Annual Global Healthcare Services Conference

February 4, 2011 4:33 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 4, 2011 /- WebMD Health Corp. (Nasdaq: WBMD ) today announced that Wayne Gattinella, President and CEO, will deliver a presentation at the UBS 21st Annual Global Healthcare Services Conference on Tuesday, February 8, 2011 at 12:00 p.m. ET. Investors, analysts and the...

TOPICS:

Aetna's 4Q profit jumps 30 percent(2)

February 4, 2011 1:46 am | by The Associated Press | Comments

Health insurer Aetna says its fourth-quarter net income rose 30 percent as it benefited from higher pricing and a slowdown in health care use that also has helped its competitors.The Hartford, Conn., insurer said Friday it earned $215.6 million, or 53 cents per share, in the three months that...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading